For example, those with a PV in MLH1 have a 71-90% lifetime risk of any Lynch cancer and a 35-90% lifetime risk of colorectal cancer whereas those with a PV in PMS2 have a 34-52% lifetime risk of any Lynch cancer and a 12-52% risk of colorectal cancer. Here, PMS2 is linked to colorectal cancer.